Cbre Investment Management Listed Real Assets LLC decreased its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 51.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 941,911 shares of the real estate investment trust's stock after selling 997,990 shares during the quarter. Cbre Investment Management Listed Real Assets LLC owned approximately 0.27% of Healthcare Realty Trust worth $15,918,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HR. Raymond James Financial Inc. bought a new stake in Healthcare Realty Trust during the 4th quarter valued at about $3,019,000. Mariner LLC increased its position in Healthcare Realty Trust by 3.9% during the 4th quarter. Mariner LLC now owns 75,194 shares of the real estate investment trust's stock valued at $1,274,000 after purchasing an additional 2,819 shares during the period. NewEdge Advisors LLC increased its position in Healthcare Realty Trust by 8.8% during the 4th quarter. NewEdge Advisors LLC now owns 27,159 shares of the real estate investment trust's stock valued at $460,000 after purchasing an additional 2,206 shares during the period. First Trust Advisors LP increased its position in Healthcare Realty Trust by 65.7% during the 4th quarter. First Trust Advisors LP now owns 186,533 shares of the real estate investment trust's stock valued at $3,162,000 after purchasing an additional 73,989 shares during the period. Finally, MetLife Investment Management LLC increased its position in Healthcare Realty Trust by 5.6% during the 4th quarter. MetLife Investment Management LLC now owns 210,156 shares of the real estate investment trust's stock valued at $3,562,000 after purchasing an additional 11,206 shares during the period.
Insiders Place Their Bets
In related news, Director Thomas N. Bohjalian acquired 10,000 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were bought at an average price of $16.46 per share, with a total value of $164,600.00. Following the completion of the acquisition, the director owned 75,520 shares in the company, valued at $1,243,059.20. This trade represents a 15.26% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.37% of the stock is currently owned by company insiders.
Healthcare Realty Trust Stock Down 0.5%
Shares of Healthcare Realty Trust stock traded down $0.09 during trading hours on Tuesday, reaching $17.03. 2,846,328 shares of the company's stock were exchanged, compared to its average volume of 3,603,890. Healthcare Realty Trust Incorporated has a 1 year low of $14.09 and a 1 year high of $18.90. The company has a market capitalization of $5.99 billion, a P/E ratio of 10.77 and a beta of 0.89. The business has a fifty day moving average of $16.12 and a two-hundred day moving average of $15.88.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $287.07 million during the quarter, compared to analyst estimates of $290.83 million. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. During the same quarter in the prior year, the firm posted $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. As a group, research analysts predict that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.
Healthcare Realty Trust Cuts Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Thursday, August 14th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 5.6%. Healthcare Realty Trust's dividend payout ratio (DPR) is -83.48%.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the stock. JPMorgan Chase & Co. cut their target price on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research report on Thursday, June 26th. Wall Street Zen downgraded shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Wells Fargo & Company cut their target price on shares of Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a research report on Monday, June 2nd. Finally, Wedbush cut their target price on shares of Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Four investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Healthcare Realty Trust presently has a consensus rating of "Reduce" and an average target price of $16.40.
View Our Latest Analysis on HR
Healthcare Realty Trust Profile
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.